Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 440,006 | 133,093 | 125,750 | 111,607 | 290,281 |
| Cost of Goods | 2,227 | 3,079 | 2,958 | 2,578 | 3,301 |
| Gross Profit | 437,779 | 130,014 | 122,792 | 109,029 | 286,980 |
| Operating Expenses | 217,403 | 215,942 | 196,719 | 201,578 | 309,945 |
| Operating Income | 220,603 | -85,849 | -72,969 | -91,971 | -22,664 |
| Interest Expense | 2,238 | 2,340 | 2,357 | 2,414 | 2,434 |
| Other Income | 6,547 | 4,416 | -5,222 | 4,646 | 10,526 |
| Pre-tax Income | 224,912 | -83,773 | -80,548 | -89,739 | -14,572 |
| Income Tax | 299 | -1,307 | 327 | 130 | 341,115 |
| Net Income Continuous | 224,613 | -82,466 | -80,875 | -89,869 | -355,687 |
| Minority Interests | N/A | N/A | N/A | N/A | -1,155 |
| Net Income | $224,613 | $-82,466 | $-80,875 | $-89,869 | $-354,532 |
| EPS Basic Total Ops | 1.59 | -0.58 | -0.57 | -0.64 | -2.54 |
| EPS Basic Continuous Ops | 1.59 | -0.58 | -0.57 | -0.64 | -2.55 |
| EPS Diluted Total Ops | 1.59 | -0.58 | -0.57 | -0.64 | -2.54 |
| EPS Diluted Continuous Ops | 1.59 | -0.58 | -0.57 | -0.64 | -2.55 |
| EBITDA(a) | $231,220 | $-75,058 | $-61,821 | $-82,233 | $-13,523 |